328 related articles for article (PubMed ID: 36187930)
21. Differential Expression of the
Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
[TBL] [Abstract][Full Text] [Related]
22. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer
Gonçalves PG; Reis RM; Bidinotto LT
Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers.
Lan A; Ren C; Wang X; Tong G; Yang G
BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293
[TBL] [Abstract][Full Text] [Related]
24. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues.
Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W
Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929
[TBL] [Abstract][Full Text] [Related]
25. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
26. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
27. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma.
Zhao C; Yu M; Li Y
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887
[TBL] [Abstract][Full Text] [Related]
28. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
Ling ZN; Hong LL; Wu J; Ling ZQ
Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of
Fei L; Lu Z; Xu Y; Hou G
Front Genet; 2022; 13():920897. PubMed ID: 36035140
[No Abstract] [Full Text] [Related]
30. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
31. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract][Full Text] [Related]
32. Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10.
Sun N; Li C; Teng Y; Deng Y; Shi L
J Oncol; 2022; 2022():1242658. PubMed ID: 36276268
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes.
Khan R; Pari B; Puszynski K
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205
[TBL] [Abstract][Full Text] [Related]
34. Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma.
Guo L; Dou Y; Yang Y; Zhang S; Kang Y; Shen L; Tang L; Zhang Y; Li C; Wang J; Liang T; Li X
Comput Struct Biotechnol J; 2021; 19():5722-5734. PubMed ID: 34745457
[TBL] [Abstract][Full Text] [Related]
35. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():927988. PubMed ID: 35756681
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer.
Wang Y; Zhang Y; Wang F; Li T; Song X; Shi H; Du J; Zhang H; Jing H; Han J; Tong D; Zhang J
Sci Rep; 2022 Nov; 12(1):18518. PubMed ID: 36323715
[TBL] [Abstract][Full Text] [Related]
37. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance.
Ma J; Jin Y; Gong B; Li L; Zhao Q
Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867
[TBL] [Abstract][Full Text] [Related]
38. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.
Ding Q; Li R; Wang Q; Yu L; Zi F
Front Oncol; 2023; 13():1049147. PubMed ID: 38053661
[TBL] [Abstract][Full Text] [Related]
39. Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis.
Shen L; Chen Q; Yang C; Wu Y; Yuan H; Chen S; Ou S; Jiang Y; Huang T; Ke L; Mo J; Feng Z; Zhou P; Fan W
Front Pharmacol; 2020; 11():593195. PubMed ID: 33384601
[No Abstract] [Full Text] [Related]
40. The function of guanylate binding protein 3 (GBP3) in human cancers by pan-cancer bioinformatics.
Jiang T; Jin P; Huang G; Li SC
Math Biosci Eng; 2023 Mar; 20(5):9511-9529. PubMed ID: 37161254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]